Introduction
Fever without source (FWS) is one of the most frequent reasons for visits to the pediatric emergency department [1, 2] . In our institution, a tertiary-care teaching hospital in the Basque Country, 3-4% of annual attendances are children below 3 years of age with fever without focal signs [3, 4] .
Most FWS are because of benign viral infections, which do not require treatment, but, sometimes, they may be because of a severe underlying bacterial infection. Streptococcus pneumoniae is the cause of many invasive diseases in children such as occult bacteremia (OB), meningitis, and bacteremic pneumonia, and it is recognized to be the main cause of OB in young children with FWS. The heptavalent pneumococcal conjugate vaccine (PCV-7) was introduced in the Basque Country in 2001 and resulted in a decline in S. pneumoniae occult bacteremia (PnOB) rate in our area [5] , attributable to a decrease in the rate of disease caused by PCV-7 serotypes as had been broadly reported in the United States [6] [7] [8] [9] .
The introduction of PCV-7 has also altered the distribution of serotypes of S. pneumoniae causing invasive disease in children, including bacteremia [10] . This decline has altered the recommendations of management of infants with FWS [11] .
Around 2-5% of infants with OB develop a serious bacterial infection (SBI), including bacterial meningitis [12] , if not treated with empirical antibiotics. One of the challenges pediatricians face is to identify wellappearing febrile children aged 3-36 months at risk of OB. To identify children with higher risk of OB, clinicians obtained complete blood counts (CBC), as it was known that the PnOB risk is increased with elevated white blood cell counts (WBC) and absolute neutrophil counts (ANC) and, in the prevaccinal era, 80-90% of OB was because of pneumococcus. In this way, it was classically reported that 6% of children with high FWS and more than 15 000 WBC/mm 3 may have a PnOB [2] , and 8% of those with an ANC higher than 10 000/mm 3 may also have a PnOB [13] , and, in fact, most practice guidelines recommendations have incorporated information derived from WBC or ANC. CBC is used by many physicians to screen febrile children for underlying bacterial infection, especially those who are young and have a highly elevated temperature, prolonged fever, or no localizing signs of infection. Changes in PnOB prevalence may have altered the yield of CBC to select patients at risk of having OB [14] . In this way, the value of CBC may be lower than reported and this fact may also alter recommendations of management of infants with fever [15] .
The aims of the study were to analyze the rate of OB in children aged 3-36 months with high FWS related to pneumococcal vaccinal status and to study the yield of the CBC and C-reactive protein (CRP) to identify children with OB in the era of PCV-7.
Patients and methods
A retrospective standardized chart review of all children aged 3-36 months presenting to the pediatric emergency department (PED) of a tertiary teaching hospital (Hospital Cruces, Basque Country, Southern Europe) was undertaken between 1 October 2004 and 30 September 2006 who had a CBC and a blood culture (BC) performed as part of their evaluation for fever.
In our PED, we strongly recommend to practice CBC, CRP, and BC in children of age 3-36 months with FWS with no doses of PCV-7 or incomplete vaccination, and we recommend to our pediatric emergency physicians not to practice those tests if a child has received at least three doses of PCV-7. Final decision (to perform or not to perform the tests) is taken by the physician attending the child (mostly a pediatric emergency physician). We decided not to change the practice of our PED when we underwent the study. In fact, in 25% of the children without a PCV-7 complete vaccination status admitted in our PED, CBC, CRP, and BC are not usually practiced [11] .
From our computerized database we identified infants visiting our emergency department diagnosed with FWS and recorded their medical record number, sex, date of birth, date of visit, vaccination status (including PCV-7. Vaccination status is reflected on the card of each patient), registered temperature in degrees centigrade (at home and triage temperature), the absence of a focal bacterial infection (including acute otitis media, pharyngitis, skin infection, or bone and joint infection), ancillary tests practiced (CBC, ANC, and CRP), and organism identified in BC.
There were two data abstractors not blinded to the study hypotheses after developing a coding manual. Patient cards were reviewed and data were extracted by a pediatric emergency resident. A pediatric emergency physician then reviewed the patient cards and the extracted data. No disagreement was detected between the two physicians.
Definitions FWS: axillary or rectal temperature registry at home or rectal registry in the PED of a temperature Z 391C, without catarrhal or respiratory symptoms/signs (such as tachypnea) or a diarrhoeal process, in a patient with a normal physical exam (no signs of acute otitis media, osteoarticular or soft tissues infection, and normal pulmonary auscultation), according to the diagnosis codification of the Spanish Society of Paediatric Emergencies [16] . In our PED, we used to register rectal temperature in young children with FWS, but, in our environment, families usually register axillary temperatures [17] and, in this way, we decided to include children with an axillary temperature Z 391C as well.
S. pneumoniae OB: only well-appearing infants aged 3-36 months diagnosed with FWS and positive BC with S. pneumoniae were considered as having an S. pneumoniae OB.
ANC was computed as the total WBC Â10
3 cells/mm 3 multiplied by the sum of the percentage of bands and polymorphonuclear cell count divided by 100. In cases in which an automated differential was computed, ANC was calculated as the WBC multiplied by the percentage of granulocytes divided by 100.
BCs characterized as true pathogens included all cultures yielding S. pneumoniae, Neisseria meningitidis, enterococcus, group A streptococcus, or Salmonella species. Growth of Staphylococcus epidermidis, Propionibacterium acnes, and diphtheroids from previously healthy immunocompetent infants (with no history of cardiac disease, ventriculoperitoneal shunts, indwelling catheters, or other prosthetic devices) were categorized as contaminants.
Inclusion criteria and exclusion criteria are exposed in Fig. 1 . Well-appearing was defined by a Pediatric Emergency physician and with a normal Pediatric Assessment Triangle (Fig. 2) after being attended by the physician. In this way, to be well appearing, the appearance, respiratory, and circulatory items had to be assessed to be normal when arriving in the PED and reflected in the chart of the patient.
Infants with abnormalities in the urine dipstick (presence of leucocyturia or nitrituria), where this screening test was utilized, were excluded. In these patients we routinely undergo WBC and BC.
Statistical and data analysis FWS, non-altered urine dipstick, and in whom physicians decided to practice a CBC and BC to identify patients at risk of having OB. Eight hundred and ninety-seven (56.6%) were male and age distribution and PCV-7 status can be seen in Figs 3 Of the 1090 infants who had received no dose or one dose of PCV-7, nine had a PnOB (0.82%, 95% confidence interval: 0.40-1.62; vs. 0.23%, 95% confidence interval: 0.01-1.49, among those with two or more doses of PCV-7, P = 0.17). PPV of WBC greater than 15 000/mm 3 in infants with no dose or one dose of PCV-7 was 1.8% (vs. 0.6% among infants with at least two doses). PPV of ANC greater than 10 000/mm 3 in infants with no dose or one dose of PCV-7 was 2.0% (vs. 0.9% among infants with at least two doses).
CRP was performed in 1572 of the cases (99.1%). CRP values were similar in PnOB group (44.1 ± 47.6 mg/l) and in children with negative BC (37.7 ± 51.5 mg/l, P = 0.68). Forty percent of children with PnOB had a CRP value higher than 20 mg/l.
Discussion
The results of this study provide additional evidence that the rate of OB in children of age 3-36 months with high FWS in the era of PCV-7 is decreasing, it seems to be different in vaccinated children and nonvaccinated children and the PPV of WBC and ANC have decreased because of the decline of PnOB incidence in wellappearing children with FWS.
Although bacteremia rates are now lower in wellappearing febrile infants, the evaluation of these patients continues being a challenge for the physician [5, 6, 8, 9, 14] . S. pneumoniae is the main cause of OB in young children with FWS. The PCV-7 has resulted in a dramatic decrease in invasive pneumococcal infections, especially meningitis and pneumococcal bacteremia, particularly in children below 2 years of age [6, 8, 9] . Although PCV-7 have not been included in the official vaccination schedule in our area, the current coverage with PCV-7 in children below 2 years of age is approximately 50% in Basque Country [11] . Despite this small PCV-7 coverage, we have recently reported a 58% decrease in the rate of PnOB among children younger than 36 months with FWS attended in our PED [5] . The results of this study confirm this earlier finding. We have found that the rate of PnOB in infants with FWS is higher in children not vaccinated or with only one dose of vaccine than in children who had received two or more doses of the PCV-7. In a recent study, Carstairs et al. [14] found similar results. They did not find any case of PnOB in infants who had received PCV-7 and the PnOB rate of 2.4% among infants who had not received this vaccine. In our study, the difference in PnOB rate between these two groups was smaller mainly because the PnOB rate among nonvaccinated infants was much lower, 0.83%. This significant difference could be explained by the starting date of both studies. Cartairs carried out the study during the first 2 years after PCV-7 was licensed in the United States. Our study was performed 5 years after the introduction of PCV-7 in Spain. A more lasting, indirect protective effect could explain a decline of PnOB also among infants who have not received PCV-7. In contrast, the age distribution of PnOB also seems to be changing, probably because of the PCV-7 effect. In an earlier study, the risk of occult pneumococcal bacteremia was significantly lower in 3-6-month-old age group than in older age groups [12] . In our study, the age distribution of PnOB has changed and 30% of PnOB below 7 months of age were detected.
Despite the reduction in the rate of OB because of the widespread use of the conjugate pneumococcal vaccine [5, 14] , the evaluation of febrile children younger than 36 months at risk of OB and SBI continues to consume health-care resources, causing transient discomfort to patients and contributing to resistance to antibiotics. In a cost-effectiveness study, Lee et al. [18] demonstrated that practicing CBC and selective BC and treatment using a WBC cutoff of 15 000 WBC/mm 3 should be cost-effective at the rate of pneumococcal bacteremia of 1.5%. This recommendation was previously made by other authors as well [19, 20] . In their article, Lee et al. [18] also affirm that if the rate of OB falls below 0.5% with the widespread use of the conjugate pneumococcal vaccine, then strategies that use empiric testing and treatment should be eliminated. Taking into consideration this cost-effectiveness analysis and the OB rates found in our study, the practice of routinely obtaining a BC and WBC count may no longer be necessary when evaluating well-appearing infants with FWS, particularly when they have received at least two doses of PCV-7.
In contrast, it has been traditionally reported that 6% of infants with FWS greater than 391C and more than 15 000 WBC/mm 3 and 8% of those with an ANC higher than 10 000/mm 3 should have a PnOB [2, 13] . The yield of WBC and ANC, however, seems to be much lower than the one reported earlier in the literature [2] , probably because of the decline of PnOB in the group of children with high FWS. Stoll et al. [6] have recently reported a 3.2% PPV of a WBC count greater or equal to 15 000/mm 3 and a 3.8% PPV of an ANC greater or equal to 10 000/mm 3 in the era of the PCV-7. Our data very well demonstrate the fact that PPVs observed in this study were lower than the PPVs observed in the earlier study. We even found the 1% PPV of both cell count limits in infants who have received PCV-7. This evidence adds more doubts about the utility of CBC in the management of febrile infants in the PCV-7 era.
Quantitative CRP concentration has been found to be a valuable laboratory test in the evaluation of febrile young children who are at risk of OB and SBI, with a better predictive value than the WBC or ANC [21] . The addition of CRP to ANC, however, seems to add a little diagnostic utility and does not add substantial diagnosis accuracy to the WBC count or ANC [22] . In our study, 60% of patients with PnOB had a CRP value less than 20 mg/l. The arrival of new, more sensitive markers of bacterial infection, such as procalcitonin, could be valuable in the management of these patients in the future [23] , as Andreola et al. [24] assessed in predicting SBI in febrile children in the emergency department.
The epidemiology of outpatient bacteremia in 3-36-month-old children is changing after the introduction of the PCV-7. In some series, the incidence of E. coli bacteremia is similar to the incidence of pneumococcal bacteremia [9] . In our study, 66% of OB was because of pneumococcus and we did not find any bacteremia because of E. coli, probably because children with altered dipstick were excluded.
Our study has several limitations. The fact that this is a retrospective study limits the collection of data. In contrast, we only included those well-appearing infants aged 3-36 months with FWS Z 391C in whom physicians obtained a CBC and BC as part of their evaluation for fever. Inclusion of all the well-appearing infants aged 3-36 months with FWS Z 391C should have had more accuracy to study the data. This fact should have implied change to our practice in the management of young children with high fever, and it does not look to be acceptable to practice these tests to those young children with a complete PCV-7 status. In our PED, before this study was carried out, we strongly recommended practicing CBC and BC in children non-PCV-7 vaccinated or with an incomplete vaccination, but tests were not practiced in one-fourth of the children as we recently reported [11] . These children were studied and did not show any difference with children included in the reported study and tests were not performed by the decision of pediatrician attending the child [11] . This fact also reflects the pediatricians' irregular compliance with the management guidelines for infants with FWS, as it has been reported by other authors [25] . We decided not to change the practice of our PED when this study was carried out, although this fact may represent a bias in the interpretation of the results. Nevertheless, none of the children in whom a CBC and BC were not obtained were admitted again in our PED with an OB or a SBI.
Recently, a replacement invasive pneumococcal disease with serotypes not covered by PCV-7 has been reported among Alaska Native children despite high PCV-7 coverage [26] . This fact and the introduction of pneumococcal conjugate vaccines including more serotypes emphasize the importance of surveillance of the yield of WBC and ANC, while evaluating previously healthy infants with high fever.
We conclude that pneumococcal bacteremia was found to be lower in well-appearing febrile infants who had received heptavalent pneumococcal conjugate vaccine. Our study supports that the strategy of routine laboratory screening and selective empirical antibiotic treatment of well-appearing febrile children below 3 years of age with two or more doses of PCV-7 must no longer be recommended.
